You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PROCHLORPERAZINE - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for prochlorperazine and what is the scope of freedom to operate?

Prochlorperazine is the generic ingredient in six branded drugs marketed by Glaxosmithkline, Padagis Us, Able, Cosette, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Somerset Theraps Llc, Teva Parenteral, Viwit Pharm, Watson Labs, Wyeth Ayerst, Ajanta Pharma Ltd, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Leading, Norvium Bioscience, Novitium Pharma, Teva Pharms, Zydus Lifesciences, and Jubilant Cadista, and is included in fifty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for prochlorperazine. Three suppliers are listed for this compound.

Summary for PROCHLORPERAZINE

US Patents:	0
Tradenames:	6
Applicants:	36
NDAs:	55
Drug Master File Entries:	21
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	57
Clinical Trials:	50
Patent Applications:	6,770
Drug Prices:	Drug price trends for PROCHLORPERAZINE
Drug Sales Revenues:	Drug sales revenues for PROCHLORPERAZINE
What excipients (inactive ingredients) are in PROCHLORPERAZINE?	PROCHLORPERAZINE excipients list
DailyMed Link:	PROCHLORPERAZINE at DailyMed

Drug Prices for PROCHLORPERAZINE

See drug prices for PROCHLORPERAZINE

Drug Sales Revenue Trends for PROCHLORPERAZINE

See drug sales revenues for PROCHLORPERAZINE

Recent Clinical Trials for PROCHLORPERAZINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Washington University School of Medicine	Phase 2
Assertio Holdings, Inc	Phase 2
Dayton Children's Hospital	N/A

See all PROCHLORPERAZINE clinical trials

Pharmacology for PROCHLORPERAZINE

Drug Class	Phenothiazine

Medical Subject Heading (MeSH) Categories for PROCHLORPERAZINE

Antiemetics
Antipsychotic Agents
Dopamine Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for PROCHLORPERAZINE

N05AB	Phenothiazines with piperazine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for PROCHLORPERAZINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Lifesciences	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	216495-002	Aug 8, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Morton Grove	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	CONCENTRATE;ORAL	088598-001	Oct 25, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glaxosmithkline	COMPAZINE	prochlorperazine maleate	TABLET;ORAL	010571-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glaxosmithkline	COMPAZINE	prochlorperazine maleate	CAPSULE, EXTENDED RELEASE;ORAL	011000-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Leading	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	218912-001	Sep 30, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Zydus Lifesciences	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	216495-001	Aug 8, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	PROCHLORPERAZINE	prochlorperazine maleate	TABLET;ORAL	085580-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.